Why is Suven Life Scie. falling/rising?

As of 10-Sep, Suven Life Sciences Ltd is experiencing a decline in its stock price, currently at 220.00, reflecting a decrease of 2.4 points or 1.08%. The stock has underperformed its sector by 1.46% today and has been on a consecutive downward trend for the last two days, with a total decline of 5.94%. It opened with a loss of 2.18% and reached an intraday low of Rs 217. Despite a strong year-to-date performance of 71.01% and a one-year return of 44.17%, the company has faced significant challenges, including operating losses and a negative EBITDA, which have contributed to its recent price movement. The company's net sales have decreased at an annual rate of 12.00%, and it has reported negative results for the last four consecutive quarters, indicating weak long-term fundamental strength.
In the broader market context, while the stock has outperformed the benchmark Sensex over the long term, it has struggled in the short term, with a one-month return of -12.11% compared to the Sensex's gain of 1.96%. The stock's recent performance is further complicated by a weak ability to service its debt, as evidenced by a poor EBIT to Interest ratio of -137.30. Despite a significant increase in investor participation, with delivery volume rising by 893.78% against the five-day average, the overall sentiment remains cautious due to the company's ongoing financial struggles and negative operating cash flow.